Cardiac Surgery
Conditions
Keywords
Psychological distress, Cognitive behavioral therapy, Fatigue, Depression, Anxiety
Brief summary
The purpose of the present pilot study is to evaluate the feasibility and potential efficacy of a brief, internet-delivered CBT protocol provided early following cardiac surgery.
Detailed description
Cardiac surgery is a major surgical procedure used to treat for example coronary artery disease (CAD). The intervention increases survival rates and reduces cardiac symptom burden in cardiac patients. However, cardiac surgery is associated with elevated symptoms of psychological distress, which are related to several negative outcomes, such as poorer health-related quality of life (QoL) and response to treatment. There is a clear need to develop a brief psychological intervention that can be provided early in the clinical course after cardiac surgery to reduce psychological distress. The purpose of this pilot study is to evaluate the feasibility and potential efficacy of a brief, exposure-based internet-delivered CBT protocol provided early after cardiac surgery. This is an uncontrolled pilot study with a pretest-posttest design. The study will include 30 participants. Assessments will be conducted pre-treatment, post-treatment, one- and six months after treatment. The one-month follow-up is the primary endpoint. The treatment lasts for five weeks and will be provided as an early intervention following cardiac surgery ≥ eight weeks to nine months before assessment. It will include psychoeducation, behavioral activation to address post-operative fatigue and depression, interoceptive exposure to reduce fear of cardiac-related symptoms and in-vivo exposure to reduce avoided situations, and activities to enhance physical activity and wellbeing.
Interventions
BEHAVIORALOnline CBT following cardiac surgery
It will include psychoeducation, behavioral activation to address post-operative fatigue and depression, interoceptive exposure to reduce fear of cardiac-related symptoms and in-vivo exposure to reduce avoided situations, and activities to enhance physical activity and wellbeing. Labeling (i.e., describing post-operative and/or cardiac-related symptoms, thoughts, and feelings) will be used continuously during treatment to enhance the effect of exposure and pain management
Sponsors
Karolinska University Hospital
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* (A) Cardiac surgery (i.e., CABG, heart valve repair/replacement, aortic repair or combined CABG and valve repair/replacement) ≥ eight weeks to nine months before assessment * (B) Age 18 years and above; * (C) Endorses postoperative psychological distress and/or interference with daily life * (D) On medical treatment for the cardiac condition according to clinical guidelines; * (E) Ability to read and write in Swedish
Exclusion criteria
* (F) Prior cardiac surgery with ventricular assist device or heart transplant; * (G) Hospitalized or living in a care facility; * (H) Any medical restriction to be physical active; * (I) Severe medical illness i.e., terminal cancer ; * (J) Severe psychiatric disorder or risk of suicide; * (K) Alcohol dependency; * (L) Ongoing psychological treatment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adverse events | Baseline to 5 weeks | Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively'). |
| 12-Item Short-Form Health Survey | Baseline to 2 months | General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life |
| Acceptability: Client satisfaction Questionnaire | Baseline to 5 weeks. | Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment. |
| Percentage of enrolled participants who complete the treatment | Baseline to 5 weeks | Feasibility of the intervention components will be assessed by \>60% assessed as treatment completers. Descriptive analysis will also provide number of messages and therapist time. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Generalized Anxiety Disorder 7-item | Baseline to 5 weeks | General anxiety, score ranging from 0-21, with a higher score indicating more anxiety and worry. |
| Brief Pain Inventory Short Form | Baseline to 5 weeks | Measure of pain interference and severity, with a higher score indicating more pain. |
| Multidimensional fatigue inventory | Baseline to 5 weeks | Measure of fatigue, with a higher score indicating more fatigue. |
| The Godin Leisure-time Exercise and International Physical Activity Questionnaire 1 item on inactivity | Baseline to weeks | evel of physical activity and inactivity: On the Godin leisure-time excercise: The participant rate numbers of time per week that they engage in physical activity. The numb ers are the categorized in to low, moderate, and high levels of physical activity. And from International Physical Activity Questionnaire we will use 1 item on inactivity |
| University of Toronto Atrial fibrillation Severity Scale (AFSS) | Baseline to 5 weeks | 3 item on cardiac-specific healthcare consumption. Scores ranges 0-15 with a higher score indicating more cardiac-related healthcare consumption. |
| Symptom checklist Severity and Frequency Scale (SCL, adapted to coronary artery disease) | Baseline to 5 weeks | Cardiac-related symptoms in two sub scales A) frequency: score ranging from 0-48, with higher score indicating higher frequency of symptoms, B) severity of experienced symptom: score ranging from 0- 48, with a higher score indicating more severe symptoms |
| 12-Item Short-Form Health Survey | Baseline to 5 weeks | General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life General quality of life, with a score ranging from 0 to 100. A higher score indicating a better quality of life |
| Cardiac anxiety questionnaire | Baseline to 5 weeks | Measure of cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 72, with a greater score indicating elevated cardiac anxiety. |
| Patient Health Questionnaire-9 | Baseline to 5 weeks | Measure of depression, score ranging 0 to 27 with a higher score indicating higher level of depression |
Other
| Measure | Time frame | Description |
|---|---|---|
| Adverse events | Baseline to 2 months | otential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively'). |
Countries
Sweden
Outcome results
None listed